These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33104113)

  • 1. Stemming the Progression of Diabetic Kidney Disease: The Role of the Primary Care Clinician.
    Bakris G
    J Fam Pract; 2020 Sep; 69(7 Suppl):S81-S86. PubMed ID: 33104113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [KIDNEY DISEASE IN DIABETIC PATIENTS – THE ROLE OF FAMILY MEDICINE PHYSICIAN].
    Lang VB; Baretić M; Pavić E
    Acta Med Croatica; 2016 Dec; 70(4-5):319-24. PubMed ID: 29087628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying and slowing progressive chronic renal failure.
    Curtis B; Barrett BJ; Levin A
    Can Fam Physician; 2001 Dec; 47():2512-8. PubMed ID: 11785282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
    Cid Ruzafa J; Paczkowski R; Boye KS; Di Tanna GL; Sheetz MJ; Donaldson R; Breyer MD; Neasham D; Voelker JR
    Int J Clin Pract; 2015 Aug; 69(8):871-82. PubMed ID: 26011029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the family physician in controlling the epidemic of chronic kidney disease.
    Bhowmik D; Baveja T; Tiwari SC
    J Indian Med Assoc; 2012 Jan; 110(1):40-2. PubMed ID: 23029829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical considerations and practical recommendations for the primary care practitioner in the management of anemia of chronic kidney disease.
    Basile JN
    South Med J; 2007 Dec; 100(12):1200-7. PubMed ID: 18090962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes mellitus patients and their importance in primary care.
    Górriz JL; Cos Claramunt FX; Duque N; Matali A
    Prim Care Diabetes; 2019 Dec; 13(6):485-494. PubMed ID: 31400992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients.
    Issar T; Arnold R; Kwai NCG; Walker S; Yan A; Borire AA; Poynten AM; Pussell BA; Endre ZH; Kiernan MC; Krishnan AV
    Clin Neurophysiol; 2019 Nov; 130(11):2088-2095. PubMed ID: 31541986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetic nephropathy: physiopathology and clinical course].
    Macía Heras M; Macía Jerez M; Coronel F
    Nefrologia; 2001; 21 Suppl 3():24-31. PubMed ID: 11642203
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetic kidney disease and obstructive sleep apnea: a new frontier?
    Al Mawed S; Unruh M
    Curr Opin Pulm Med; 2016 Jan; 22(1):80-8. PubMed ID: 26574721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients.
    Schumock GT; Andress DL; Marx SE; Sterz R; Joyce AT; Kalantar-Zadeh K
    Nephron Clin Pract; 2009; 113(1):c54-61. PubMed ID: 19590235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.
    Wagner M; Ashby DR; Kurtz C; Alam A; Busbridge M; Raff U; Zimmermann J; Heuschmann PU; Wanner C; Schramm L
    PLoS One; 2015; 10(4):e0123072. PubMed ID: 25894587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression: treating a familiar enemy.
    Anderson EG
    Geriatrics; 1991 Nov; 46(11):71-2. PubMed ID: 1937063
    [No Abstract]   [Full Text] [Related]  

  • 14. The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy.
    Sato A
    Hypertens Res; 2015 Jun; 38(6):367-74. PubMed ID: 25762415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of diabetic nephropathy: role of hypertension.
    Giunti S; Barit D; Cooper ME
    Hypertension; 2006 Oct; 48(4):519-26. PubMed ID: 16952978
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelin A receptor antagonists in diabetic kidney disease.
    Georgianos PI; Agarwal R
    Curr Opin Nephrol Hypertens; 2017 Sep; 26(5):338-344. PubMed ID: 28520568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk of progression of chronic kidney disease in diabetics and hypertensive patients followed in primary care in Madrid.
    Alemán-Vega G; Gómez Cabañas I; Reques Sastre L; Rosado Martín J; Polentinos-Castro E; Rodríguez Barrientos R
    Nefrologia; 2017; 37(3):343-345. PubMed ID: 28648211
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluorophores advanced glycation end products (AGEs)-to-NADH ratio is predictor for diabetic chronic kidney and cardiovascular disease.
    Ciobanu DM; Olar LE; Stefan R; Veresiu IA; Bala CG; Mircea PA; Roman G
    J Diabetes Complications; 2015; 29(7):893-7. PubMed ID: 26169772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health Care in 2030: Will Artificial Intelligence Replace Physicians?
    Shah NR
    Ann Intern Med; 2019 Mar; 170(6):407-408. PubMed ID: 30802901
    [No Abstract]   [Full Text] [Related]  

  • 20. Health care and more health care.
    Reppun JI
    Hawaii Med J; 1993 Jan; 52(1):6. PubMed ID: 8444610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.